Dr. Weldon E. Collins, M.D.
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- Baylor College of Medicine (1981)
- Years since graduation
- 45
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,217
Licensed in Texas since 1981, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1981Medical school: Baylor College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
TX license F9316 (first issued 1981; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- W Edward Collins MD PA (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,217
- Services billed
- 5,837
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 2,041 | 338 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,336 | 1,057 |
| Destruction of precancer skin growth, 1 growth | 689 | 466 |
| Destruction of skin growth, 1-14 growths | 521 | 443 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 381 | 57 |
| Established patient office or other outpatient visit, 30-39 minutes | 151 | 145 |
| Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | 140 | 110 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 114 | 91 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 94 | 38 |
| Established patient office or other outpatient visit, 10-19 minutes | 91 | 84 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 35 payments worth $1,446 in total to this clinician.
| Janssen Biotech, Inc. | $346 |
|---|---|
| AbbVie Inc. | $271 |
| UCB, Inc. | $248 |
| Genzyme Corporation | $156 |
| Arcutis Biotherapeutics, Inc. | $111 |
| Lilly USA, LLC | $105 |
| Incyte Corporation | $94.29 |
| Mallinckrodt Hospital Products Inc. | $23.39 |
| Food and Beverage | $1,382 |
|---|---|
| Education | $64.95 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. May 20, 2025 | Education TREMFYA · Immunology · in-kind | $64.95 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.